ABOUT US

Neuro-Bio Ltd was incorporated in 2013, from almost 40 years of research by Professor Baroness Greenfield at Oxford University, when seed funding enabled the first patent filing on chemical composition of matter for neuroprotection.

The company started at Milton Park, Oxfordshire in 2014. From then on, the company expanded the scientific team and moved to more ample offices and labs at the Culham Campus, Oxfordshire which were subsequently refurbished to meet our bespoke requirements.

Since 2015, Neuro-Bio has been validated and developing a biomarker and a diagnostic, both based on its novel hypothesis of the neurodegenerative process in AD, that for the first-time accounted for all the known clinical facts.